Filing Flows

Filing Flows › CME Group (CME) › Q1 2026

CME Group (CME) Q1 2026 earnings results (first quarter 2026)

10-Q filed Apr 24, 2026

CME Group (CME) reported revenue of $1.9B for the first quarter 2026 (Q1 2026), +14% from a year earlier and +14% from the quarter before. Operating margin was 69.7%, net earnings $1.2B (62.1% of revenue).

Revenue$1.9B
Year over year+14%
Quarter over quarter+14%
Operating margin69.7%
Net earnings$1.2B

CME Group, Q1 2026: revenue $1.9B (+14% year over year), operating margin 69.7%, net earnings $1.2B, operating cash flow $1.3B. The chart follows the revenue to costs, profit and cash.

Q1 2026AmountQ/QY/Y
Revenue$1.9B+14%+14%
Operating profit$1.3B+28%+18%
Net earnings$1.2B-1%+24%
Operating cash flow$1.3B+11%+13%
Free cash flow$1.2B+12%+12%

What changed

Revenue was $1.9B in Q1 2026, up 14% year over year and up 14% from the previous quarter. Clearing and transaction fees was the largest line at 82% of revenue. Clearing and transaction fees added $0.21B year over year (up 15%), 86% of the total change.

Operating profit was $1.3B, a 69.7% margin (up 2.2 points year over year). Of the extra revenue versus Q1 2025, 85% reached operating profit, above the 67% margin then. Total costs grew 7% against revenue growth of 14%. Net earnings were $1.2B, up 24% year over year ($1.2B including minority interests, which bore $0.01B of losses). The effective tax rate was 23.6%.

Operating cash flow was $1.3B (up 13% year over year), 109% of net earnings. Non-cash charges added back $0.08B of depreciation and amortization and $0.02B of share-based compensation. Capital expenditures of $0.02B left free cash flow of $1.2B.

Questions

What was CME Group's revenue in the first quarter 2026?

CME Group (CME) reported revenue of $1.9B for the first quarter 2026 (Q1 2026), +14% from a year earlier and +14% from the quarter before.

Was CME Group profitable in the first quarter 2026?

Operating profit was $1.3B (69.7% of revenue) and net earnings $1.2B.

Open the interactive Sankey →

Source: CME Group 10-Q on SEC EDGAR.